Prev：Repurposing HIV protease inhibitors as senotherapeutic agents in cervical cancer: Dual targeting of CDK1/6-cell cycle arrest and p53/p21/p16 signaling axis.(A23420-2.2)
Next：Repurposing of Phosphodiesterase-5 Inhibitors as Therapeutic Agents Against Human Gastric Cancer(A23420-)
